Pages that link to "Q41267125"

The following pages link to Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). (Q41267125):

Displaying 38 items.

• Primary structure of a putative serine protease specific for IGF-binding proteins (Q28300113) (← links)
• Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzyme (Q30673942) (← links)
• Growth hormone and prostate cancer: guilty by association? (Q33708557) (← links)
• Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis (Q33853206) (← links)
• Insulin-Like growth factor I: implications in aging (Q33873279) (← links)
• Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers. (Q34330174) (← links)
• Inhibition of GH release of rats by new potent antagonists of growth hormone-releasing hormone (GH-RH). (Q34425635) (← links)
• Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia (Q34445822) (← links)
• Growth factors and their receptors in prostate cancer (Q34539272) (← links)
• Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells (Q34695649) (← links)
• Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro (Q35066088) (← links)
• Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors (Q36224883) (← links)
• Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone (Q36421721) (← links)
• Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha (Q36513180) (← links)
• Small cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2 (Q37286761) (← links)
• Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions (Q37418923) (← links)
• AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth (Q37565415) (← links)
• Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients. (Q38307842) (← links)
• IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells (Q38314601) (← links)
• A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. (Q38348323) (← links)
• Nedd4-induced monoubiquitination of IRS-2 enhances IGF signalling and mitogenic activity. (Q38886538) (← links)
• HIF-1 alpha: a key survival factor for serum-deprived prostate cancer cells (Q39970929) (← links)
• Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator. (Q40523359) (← links)
• IGFBP-3 mediates p53-induced apoptosis during serum starvation. (Q40718202) (← links)
• IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation (Q40874616) (← links)
• IGFBP-2 expression in a human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorigenicity (Q41013044) (← links)
• Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells (Q41071550) (← links)
• Insulin-like growth factor binding protein-3 and-5 are regulated by transforming growth factor-β and retinoic acid in the human prostate adenocarcinoma cell line PC-3 (Q41105940) (← links)
• Regulation of prostate cell growth by the insulin-like growth factor binding proteins and their proteases (Q41693168) (← links)
• Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor (Q44059662) (← links)
• Plasmin proteolyzes IGF:IGFBP-3:ALS (Q50296761) (← links)
• IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line (Q58553062) (← links)
• Gene expression of insulin-like growth factors and receptors in neoplastic prostate tissues: correlation with clinico-pathological parameters (Q73723999) (← links)
• Surface-bound plasmin induces selective proteolysis of insulin-like-growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF-II bio-availability in human colon-carcinoma cells (Q73734369) (← links)
• The amino-terminal region of insulin-like growth factor binding protein-3, (1-95)IGFBP-3, induces apoptosis of MCF-7 breast carcinoma cells (Q74259360) (← links)
• Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone (Q78733357) (← links)
• Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells (Q79547974) (← links)
• Diet, physical activity and energy balance and their impact on breast and prostate cancers (Q82953724) (← links)